Search Results - "Cheal, Sarah"

Pretargeting: A Path Forward for Radioimmunotherapy.

Authors: Cheal, Sarah M. Chung, Sebastian K. Vaughn, Brett A. et al.

Source: Journal of Nuclear Medicine. Sep2022, Vol. 63 Issue 9, p1302-1315. 14p. 2 Charts, 3 Graphs.

This result is not displayed to guests.
Login for full access.

Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.

Authors: Cheal, Sarah M. Fung, Edward K. Patel, Mitesh et al.

Source: Journal of Nuclear Medicine. Nov2017, Vol. 58 Issue 11, p1735-1742. 8p. 1 Diagram, 3 Charts, 5 Graphs.

Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity Y- or Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.

Authors: Cheal, Sarah Xu, Hong Guo, Hong-fen et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. May2016, Vol. 43 Issue 5, p925-937. 13p.

Pairwise comparison of Zr- and I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.

Authors: Cheal, Sarah Punzalan, Blesida Doran, Michael et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. May2014, Vol. 41 Issue 5, p985-994. 10p.

Preclinical ^203/212Pb-DOTA–Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts.

Authors: Vaughn, Brett A. Veach, Darren R. Vargas, Daniela Burnes et al.

Source: Journal of Nuclear Medicine. May2026, Vol. 67 Issue 5, p700-708. 9p.

This result is not displayed to guests.
Login for full access.

²²⁵Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2–Expressing Breast Cancer.

Authors: Rinne, Sara S. Burnes Vargas, Daniela Seo, Shin et al.

Source: Journal of Nuclear Medicine. Nov2025, Vol. 66 Issue 11, p1714-1721. 8p.

O-04 - Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer.

Authors: Le Roux, Alexandre Cheal, Sarah Veach, Darren et al.

Source: Nuclear Medicine & Biology. 2021:Supplement, Vol. 96, pS3-S4. 2p.

Imaging metastatic castration-resistant prostate cancer patients with ⁸⁹Zr-DFO-MSTP2109A anti-STEAP1 antibody.

Authors: Carrasquillo, Jorge A. Fine, Bernard M. Pandit-Taskar, Neeta et al.

Source: Journal of Nuclear Medicine. Dec2019, Vol. 60 Issue 12, p1-28. 28p. 2 Color Photographs, 2 Charts, 1 Graph.

Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.

Authors: Pandit-Taskar, Neeta O'Donoghue, Joseph Beylergil, Volkan et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2014, Vol. 41 Issue 11, p2093-2105. 13p.

First-in-Human Imaging with ⁸⁹Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.

Authors: Pandit-Taskar, Neeta O'Donoghue, Joseph A. Ruan, Shutian et al.

Source: Journal of Nuclear Medicine. Dec2016, Vol. 57 Issue 12, p1858-1864. 7p. 2 Color Photographs, 1 Black and White Photograph, 1 Diagram, 1 Chart, 4 Graphs.

Imaging Tumor Burden in the Brain with ⁸⁹Zr-Transferrin.

Authors: Evans, Michael J. Holland, Jason P. Rice, Samuel L. et al.

Source: Journal of Nuclear Medicine. Jan2013, Vol. 54 Issue 1, p90-95. 6p. 3 Color Photographs.

Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations.

Authors: Feng Chen Kai Ma Benezra, Miriam et al.

Source: Chemistry of Materials. 10/24/2017, Vol. 29 Issue 20, p8766-8779. 14p.

Development of a MR-Visible Compound for Tracing Neuroanatomical Connections In Vivo

Authors: Wu, Carolyn W.-H. Vasalatiy, Olga Liu, Ning et al.

Source: Neuron. Apr2011, Vol. 70 Issue 2, p229-243. 15p.

P-019 - Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy.

Authors: Veach, Darren Vaughn, Brett Vargas, Daniela Burnes et al.

Source: Nuclear Medicine & Biology. 2022 Supplement, Vol. 108, pS61-S62. 2p.

NMB-3 - 111In/225Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: preclinical SPECT and autoradiography studies.

Authors: Chung, Sebastian Chandler, Christopher Veach, Darren et al.

Source: Nuclear Medicine & Biology. 2022 Supplement, Vol. 108, pS50-S50. 1p.

Preclinical ^203/212Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts.

Authors: Vaughn BA Veach DR Vargas DB et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 700-708. Date of Electronic Publication: 2026 May 01.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Pretargeted ¹⁷⁷Lu/²²⁵Ac combination therapy of colorectal cancer.

Authors: Rinne SS Salehi N Vaughn BA et al.

Source: Theranostics [Theranostics] 2026 Apr 08; Vol. 16 (11), pp. 5898-5910. Date of Electronic Publication: 2026 Apr 08 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

²²⁵Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast Cancer.

Authors: Rinne SS Burnes Vargas D Seo S et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Nov 03; Vol. 66 (11), pp. 1714-1721. Date of Electronic Publication: 2025 Nov 03.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE